At a glance
ClinicalIndex Comparison RecordN/ACompleted· 21 enrolled
Drug / intervention
Caffeine and glucose +2 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Does Combined Caffeine and Carbohydrate Ingestion Counter the Exercise-mediated Fall in Glycaemia in Individuals With Type 1 Diabetes on Insulin Degludec? The DE-CAF Study
In Brief
A clinical study evaluating Caffeine and glucose, Glucose alone, and 1 other intervention for Caffeine and Carbohydrate and 2 related conditions. Completed, enrolled 21 participants across 1 site.
Detailed Summary
This project will aim to investigate the clinical efficacy and metabolic effects of a pre-exercise dose of caffeine with a low (10g) dose of carbohydrate (CAF+lowCHO) without modification of insulin degludec on exercise metabolism in people with T1D.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCaffeine and Carbohydrate, Carbohydrate Only, Placebo
CountriesSwitzerland
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedDec 2020
Enrollment StartFeb 2022
Primary CompletionFeb 2023
TodayJul 2026
First PostedDec 17, 2020
Enrollment StartFeb 4, 2022
Primary CompletionFeb 2, 2023
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 5.5 years ago
Interventions
Caffeine and glucosedietary
Caffeine and glucose powder dissolved in water
Glucose alonedietary
Glucose powder dissolved in water
Placebodietary
Artificial sweetener dissolved in water